12 Health Care Stocks Moving In Tuesday's Intraday Session

Author: Benzinga Insights | March 07, 2023 01:31pm

Gainers

• Virax Biolabs Group (NASDAQ:VRAX) stock moved upwards by 118.6% to $1.45 during Tuesday's regular session. The current volume of 54.8 million shares is 11836.1% of Virax Biolabs Group's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $18.5 million.
• Unicycive Therapeutics (NASDAQ:UNCY) stock moved upwards by 38.7% to $1.72. As of 12:30 EST, Unicycive Therapeutics's stock is trading at a volume of 78.1 million, which is 3827.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $25.9 million.
• Bionomics (NASDAQ:BNOX) stock increased by 31.94% to $4.75. Trading volume for Bionomics's stock is 2.6 million as of 12:30 EST. This is 25158.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $38.7 million.
• Protagonist Therapeutics (NASDAQ:PTGX) shares increased by 31.64% to $20.01. Protagonist Therapeutics's stock is trading at a volume of 10.8 million shares as of 12:30 EST. This is 995.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $984.4 million.
• Novo Integrated Sciences (NASDAQ:NVOS) shares rose 24.71% to $0.22. As of 12:30 EST, Novo Integrated Sciences's stock is trading at a volume of 142.9 million, which is 753.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $12.9 million.
• Allakos (NASDAQ:ALLK) stock rose 21.29% to $6.55. The current volume of 1.7 million shares is 176.0% of Allakos's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $558.0 million. As per the press release, Q4 earnings came out yesterday.

Losers

• Cara Therapeutics (NASDAQ:CARA) shares decreased by 29.4% to $7.07 during Tuesday's regular session. The current volume of 3.5 million shares is 922.8% of Cara Therapeutics's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $379.8 million. As per the press release, Q4 earnings came out yesterday.
• Ambrx Biopharma (NYSE:AMAM) shares fell 24.81% to $9.43. As of 12:30 EST, Ambrx Biopharma's stock is trading at a volume of 8.2 million, which is 108.1% of its average full-day volume over the last 100 days. The company's market cap stands at $364.1 million.
• Zynex (NASDAQ:ZYXI) shares declined by 19.63% to $9.97. Zynex's stock is trading at a volume of 711.3K shares as of 12:30 EST. This is 284.6% of its average full-day volume over the last 100 days. The company's market cap stands at $384.0 million.
• Vallon Pharmaceuticals (NASDAQ:VLON) shares decreased by 17.56% to $0.49. Vallon Pharmaceuticals's stock is trading at a volume of 1.0 million shares as of 12:30 EST. This is 11.0% of its average full-day volume over the last 100 days. The company's market cap stands at $6.6 million.
• Zevra Therapeutics (NASDAQ:ZVRA) shares declined by 15.8% to $4.5. Zevra Therapeutics's stock is trading at a volume of 747.6K shares as of 12:30 EST. This is 527.4% of its average full-day volume over the last 100 days. The company's market cap stands at $155.4 million. As per the news, the Q4 earnings report came out today.
• Kala Pharmaceuticals (NASDAQ:KALA) stock fell 15.54% to $18.87. The current volume of 925.3K shares is 34.1% of Kala Pharmaceuticals's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $38.2 million. As per the news, the Q4 earnings report came out 2 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ALLK AMAM BNOX CARA KALA NVOS PTGX UNCY VLON VRAX ZVRA ZYXI